Cargando…
Lipidomic signatures align with inflammatory patterns and outcomes in critical illness
Alterations in lipid metabolism have the potential to be markers as well as drivers of pathobiology of acute critical illness. Here, we took advantage of the temporal precision offered by trauma as a common cause of critical illness to identify the dynamic patterns in the circulating lipidome in cri...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647252/ https://www.ncbi.nlm.nih.gov/pubmed/36357394 http://dx.doi.org/10.1038/s41467-022-34420-4 |
_version_ | 1784827347472482304 |
---|---|
author | Wu, Junru Cyr, Anthony Gruen, Danielle S. Lovelace, Tyler C. Benos, Panayiotis V. Das, Jishnu Kar, Upendra K. Chen, Tianmeng Guyette, Francis X. Yazer, Mark H. Daley, Brian J. Miller, Richard S. Harbrecht, Brian G. Claridge, Jeffrey A. Phelan, Herb A. Zuckerbraun, Brian S. Neal, Matthew D. Johansson, Pär I. Stensballe, Jakob Namas, Rami A. Vodovotz, Yoram Sperry, Jason L. Billiar, Timothy R. |
author_facet | Wu, Junru Cyr, Anthony Gruen, Danielle S. Lovelace, Tyler C. Benos, Panayiotis V. Das, Jishnu Kar, Upendra K. Chen, Tianmeng Guyette, Francis X. Yazer, Mark H. Daley, Brian J. Miller, Richard S. Harbrecht, Brian G. Claridge, Jeffrey A. Phelan, Herb A. Zuckerbraun, Brian S. Neal, Matthew D. Johansson, Pär I. Stensballe, Jakob Namas, Rami A. Vodovotz, Yoram Sperry, Jason L. Billiar, Timothy R. |
author_sort | Wu, Junru |
collection | PubMed |
description | Alterations in lipid metabolism have the potential to be markers as well as drivers of pathobiology of acute critical illness. Here, we took advantage of the temporal precision offered by trauma as a common cause of critical illness to identify the dynamic patterns in the circulating lipidome in critically ill humans. The major findings include an early loss of all classes of circulating lipids followed by a delayed and selective lipogenesis in patients destined to remain critically ill. The previously reported survival benefit of early thawed plasma administration was associated with preserved lipid levels that related to favorable changes in coagulation and inflammation biomarkers in causal modelling. Phosphatidylethanolamines (PE) were elevated in patients with persistent critical illness and PE levels were prognostic for worse outcomes not only in trauma but also severe COVID-19 patients. Here we show selective rise in systemic PE as a common prognostic feature of critical illness. |
format | Online Article Text |
id | pubmed-9647252 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-96472522022-11-14 Lipidomic signatures align with inflammatory patterns and outcomes in critical illness Wu, Junru Cyr, Anthony Gruen, Danielle S. Lovelace, Tyler C. Benos, Panayiotis V. Das, Jishnu Kar, Upendra K. Chen, Tianmeng Guyette, Francis X. Yazer, Mark H. Daley, Brian J. Miller, Richard S. Harbrecht, Brian G. Claridge, Jeffrey A. Phelan, Herb A. Zuckerbraun, Brian S. Neal, Matthew D. Johansson, Pär I. Stensballe, Jakob Namas, Rami A. Vodovotz, Yoram Sperry, Jason L. Billiar, Timothy R. Nat Commun Article Alterations in lipid metabolism have the potential to be markers as well as drivers of pathobiology of acute critical illness. Here, we took advantage of the temporal precision offered by trauma as a common cause of critical illness to identify the dynamic patterns in the circulating lipidome in critically ill humans. The major findings include an early loss of all classes of circulating lipids followed by a delayed and selective lipogenesis in patients destined to remain critically ill. The previously reported survival benefit of early thawed plasma administration was associated with preserved lipid levels that related to favorable changes in coagulation and inflammation biomarkers in causal modelling. Phosphatidylethanolamines (PE) were elevated in patients with persistent critical illness and PE levels were prognostic for worse outcomes not only in trauma but also severe COVID-19 patients. Here we show selective rise in systemic PE as a common prognostic feature of critical illness. Nature Publishing Group UK 2022-11-10 /pmc/articles/PMC9647252/ /pubmed/36357394 http://dx.doi.org/10.1038/s41467-022-34420-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Wu, Junru Cyr, Anthony Gruen, Danielle S. Lovelace, Tyler C. Benos, Panayiotis V. Das, Jishnu Kar, Upendra K. Chen, Tianmeng Guyette, Francis X. Yazer, Mark H. Daley, Brian J. Miller, Richard S. Harbrecht, Brian G. Claridge, Jeffrey A. Phelan, Herb A. Zuckerbraun, Brian S. Neal, Matthew D. Johansson, Pär I. Stensballe, Jakob Namas, Rami A. Vodovotz, Yoram Sperry, Jason L. Billiar, Timothy R. Lipidomic signatures align with inflammatory patterns and outcomes in critical illness |
title | Lipidomic signatures align with inflammatory patterns and outcomes in critical illness |
title_full | Lipidomic signatures align with inflammatory patterns and outcomes in critical illness |
title_fullStr | Lipidomic signatures align with inflammatory patterns and outcomes in critical illness |
title_full_unstemmed | Lipidomic signatures align with inflammatory patterns and outcomes in critical illness |
title_short | Lipidomic signatures align with inflammatory patterns and outcomes in critical illness |
title_sort | lipidomic signatures align with inflammatory patterns and outcomes in critical illness |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647252/ https://www.ncbi.nlm.nih.gov/pubmed/36357394 http://dx.doi.org/10.1038/s41467-022-34420-4 |
work_keys_str_mv | AT wujunru lipidomicsignaturesalignwithinflammatorypatternsandoutcomesincriticalillness AT cyranthony lipidomicsignaturesalignwithinflammatorypatternsandoutcomesincriticalillness AT gruendanielles lipidomicsignaturesalignwithinflammatorypatternsandoutcomesincriticalillness AT lovelacetylerc lipidomicsignaturesalignwithinflammatorypatternsandoutcomesincriticalillness AT benospanayiotisv lipidomicsignaturesalignwithinflammatorypatternsandoutcomesincriticalillness AT dasjishnu lipidomicsignaturesalignwithinflammatorypatternsandoutcomesincriticalillness AT karupendrak lipidomicsignaturesalignwithinflammatorypatternsandoutcomesincriticalillness AT chentianmeng lipidomicsignaturesalignwithinflammatorypatternsandoutcomesincriticalillness AT guyettefrancisx lipidomicsignaturesalignwithinflammatorypatternsandoutcomesincriticalillness AT yazermarkh lipidomicsignaturesalignwithinflammatorypatternsandoutcomesincriticalillness AT daleybrianj lipidomicsignaturesalignwithinflammatorypatternsandoutcomesincriticalillness AT millerrichards lipidomicsignaturesalignwithinflammatorypatternsandoutcomesincriticalillness AT harbrechtbriang lipidomicsignaturesalignwithinflammatorypatternsandoutcomesincriticalillness AT claridgejeffreya lipidomicsignaturesalignwithinflammatorypatternsandoutcomesincriticalillness AT phelanherba lipidomicsignaturesalignwithinflammatorypatternsandoutcomesincriticalillness AT zuckerbraunbrians lipidomicsignaturesalignwithinflammatorypatternsandoutcomesincriticalillness AT nealmatthewd lipidomicsignaturesalignwithinflammatorypatternsandoutcomesincriticalillness AT johanssonpari lipidomicsignaturesalignwithinflammatorypatternsandoutcomesincriticalillness AT stensballejakob lipidomicsignaturesalignwithinflammatorypatternsandoutcomesincriticalillness AT namasramia lipidomicsignaturesalignwithinflammatorypatternsandoutcomesincriticalillness AT vodovotzyoram lipidomicsignaturesalignwithinflammatorypatternsandoutcomesincriticalillness AT sperryjasonl lipidomicsignaturesalignwithinflammatorypatternsandoutcomesincriticalillness AT billiartimothyr lipidomicsignaturesalignwithinflammatorypatternsandoutcomesincriticalillness AT lipidomicsignaturesalignwithinflammatorypatternsandoutcomesincriticalillness |